73 related articles for article (PubMed ID: 19679305)
41. [Mast cell reaction after the action of quartz in isotonic and non-isotonic suspension in the intraperitoneal test on the mouse].
RONDEZ R; RUETTNER JR; ANDERS G
Med Exp Int J Exp Med; 1959; 1():33-7. PubMed ID: 14438675
[No Abstract] [Full Text] [Related]
42. Erratum to: Measurement of Macrophage-Specific In Vivo Reverse Cholesterol Transport in Mice.
Kockx M; Jessup W; Kritharides L
Methods Mol Biol; 2017; 1583():E1. PubMed ID: 28455609
[No Abstract] [Full Text] [Related]
43. Intramyocardial hemorrhage drives fatty degeneration of infarcted myocardium.
Cokic I; Chan SF; Guan X; Nair AR; Yang HJ; Liu T; Chen Y; Hernando D; Sykes J; Tang R; Butler J; Dohnalkova A; Kovarik L; Finney R; Kali A; Sharif B; Bouchard LS; Gupta R; Krishnam MS; Vora K; Tamarappoo B; Howarth AG; Kumar A; Francis J; Reeder SB; Wood JC; Prato FS; Dharmakumar R
Nat Commun; 2022 Oct; 13(1):6394. PubMed ID: 36302906
[TBL] [Abstract][Full Text] [Related]
44. The Functional Role of Lipoproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy.
Lu Y; Cui X; Zhang L; Wang X; Xu Y; Qin Z; Liu G; Wang Q; Tian K; Lim KS; Charles CJ; Zhang J; Tang J
Aging Dis; 2022 Apr; 13(2):491-520. PubMed ID: 35371605
[TBL] [Abstract][Full Text] [Related]
45. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
[TBL] [Abstract][Full Text] [Related]
46. Interaction between allergic asthma and atherosclerosis.
Liu CL; Zhang JY; Shi GP
Transl Res; 2016 Aug; 174():5-22. PubMed ID: 26608212
[TBL] [Abstract][Full Text] [Related]
47. Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.
Kareinen I; Cedó L; Silvennoinen R; Laurila PP; Jauhiainen M; Julve J; Blanco-Vaca F; Escola-Gil JC; Kovanen PT; Lee-Rueckert M
J Lipid Res; 2015 Feb; 56(2):241-53. PubMed ID: 25473102
[TBL] [Abstract][Full Text] [Related]
48. Mast cells as effectors in atherosclerosis.
Bot I; Shi GP; Kovanen PT
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
[TBL] [Abstract][Full Text] [Related]
49. Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.
Wang J; Sjöberg S; Tia V; Secco B; Chen H; Yang M; Sukhova GK; Shi GP
Atherosclerosis; 2013 Aug; 229(2):304-9. PubMed ID: 23880180
[TBL] [Abstract][Full Text] [Related]
50. Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.
Xu JM; Shi GP
Endocr Rev; 2012 Feb; 33(1):71-108. PubMed ID: 22240242
[TBL] [Abstract][Full Text] [Related]
51. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
52. The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significance.
Lee-Rueckert M; Kovanen PT
Curr Opin Lipidol; 2015 Oct; 26(5):362-8. PubMed ID: 26339766
[TBL] [Abstract][Full Text] [Related]
53. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo.
Judström I; Jukkola H; Metso J; Jauhiainen M; Kovanen PT; Lee-Rueckert M
Atherosclerosis; 2010 Jan; 208(1):148-54. PubMed ID: 19679305
[TBL] [Abstract][Full Text] [Related]
54. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
55. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport.
Lee-Rueckert M; Kovanen PT
Atherosclerosis; 2006 Nov; 189(1):8-18. PubMed ID: 16530202
[TBL] [Abstract][Full Text] [Related]
56. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
